Harrow, Inc. Common Stock (HROW) is a publicly traded Healthcare sector company. As of September 4, 2026, HROW trades at $38.53 with a market cap of $1.43B and a P/E ratio of -274.55. HROW moved +0.60% today. Year to date, HROW is -29.67%; over the trailing twelve months it is +4.19%. Its 52-week range spans $20.85 to $54.85. Analyst consensus is strong buy with an average price target of $66.67. Rallies surfaces HROW's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest HROW news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $38.53 |
| Market Cap | $1.43B |
| P/E Ratio | -274.55 |
| EPS | $-0.14 |
| Dividend Yield | 0.00% |
| 52-Week High | $54.85 |
| 52-Week Low | $20.85 |
| Volume | 195.23K |
| Avg Volume | 0 |
| Revenue (TTM) | $272.30M |
| Net Income | $-5.14M |
| Gross Margin | 75.05% |
7 analysts cover HROW: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $66.67.